Townsend Richard Nolan Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
5
Insider Sells Sum
$152,907.64

Insider Activity of Townsend Richard Nolan

According to the SEC Form 4 filings, Townsend Richard Nolan, being in a position of

  1. Chief Executive Officer at Lexeo Therapeutics, Inc. Common Stock,
    оver the last 12 months, has bought 0 shares, and sold 98934 shares for $538,240,
    over all time since 2024-09-10, has bought 0 shares, and sold 135202 shares for $824,330.

Biography of Townsend Richard Nolan

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$538,2406100

Comparison of Insiders on Amount of Buys and Sells

2026-08-18SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Executive Officer
3,345
0.0043%
$4.95$16,562-29.61%
2026-07-01SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Executive Officer
25,947
0.0318%
$4.48$116,243-1.35%
2026-05-18SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Executive Officer
3,342
0.0046%
$5.06$16,927-3.4%
2026-04-06SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Executive Officer
55,000
0.0744%
$5.69$313,137-18.37%
2026-02-18SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Executive Officer
10,173
0.0141%
$6.38$64,924-23.05%
2025-11-18SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Executive Officer
1,127
0.0034%
$9.27$10,447-41.01%
2025-10-17SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Executive Officer
13,133
0.0369%
$8.94$117,436-39.77%
2025-08-18SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Executive Officer
2,735
0.0078%
$4.67$12,767+28.25%
2025-05-16SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Executive Officer
1,074
0.0028%
$2.77$2,979+94.75%
2025-02-19SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Executive Officer
4,326
0.0133%
$4.41$19,091+7.17%
2024-12-10SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Executive Officer
2,500
0.0076%
$8.20$20,491-43.54%
2024-11-11SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Executive Officer
2,500
0.0072%
$7.82$19,557-40.63%
2024-10-10SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Executive Officer
5,000
0.0149%
$8.10$40,496-40.7%
2024-09-10SaleLexeo Therapeutics, Inc. Common Stock
LXEO
Chief Executive Officer
5,000
0.0196%
$10.65$53,274-54.4%
Total: 14
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.